FDA Clearance Tracker · P200031-S006
Organ Care System (OCS®) Liver
Last checked: Nov 20, 2026Latest source record: Feb 23, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 23, 2024
Approved
Time to decision
177 days
Received Aug 30, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P200031-S006
- Device name
- Organ Care System (OCS®) Liver
- Applicant
- TransMedics, Inc.
- Applicant location
- Andover, MA
- Received
- Aug 30, 2023
- Decided
- Feb 23, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P200031
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) 180-day supplement, which requested approval for labeling changes including the research methods and results of the 2-year PROTECT CAP Continuation PAS.
Source documents
Other decisions for TransMedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231362 · Decided Oct 31, 2023 · 173 days after receipt
Device type: Filter, Blood, Cardiopulmonary Bypass, Arterial Line (DTM) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.